we have studied the plasma pharmacokinetics of idarubicin ( 4-demethoxy daunorubicin ) in 11 elderly patients suffering from acute myeloblastic leukemia receiving orally 30 mg/m2 per day for 3 consecutive days .
C0020789
idarubicin
C0011015
daunorubicin